MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Rachel Bayley, Daniel Blakemore, Paloma García*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)37460-37461
Number of pages2
Issue number101
Publication statusPublished - 1 Dec 2018


  • Aging
  • Blood disorders
  • DNA repair
  • MDS
  • Stem cells

ASJC Scopus subject areas

  • Oncology

Cite this